26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

cell-bound antibody (cell-fixed antibody) 159 cell separation methods<br />

Most are grouped into protein families that include the<br />

integrins, selectins, mucin-like proteins, and the immunoglobulin<br />

superfamily.<br />

cell-bound antibody (cell-fixed antibody)<br />

An antibody anchored to the cell surface either through its<br />

paratopes binding to cell epitopes or attachment of its Fc<br />

region to Fc receptors. An example is cytophilic antibody or<br />

IgE which may then react with antigens as their Fab regions<br />

are available.<br />

cell cooperation<br />

T lymphocyte and B lymphocyte cooperation.<br />

cell line<br />

Cultured neoplastic cells or normal cells that have been<br />

transformed by chemicals or viruses. Transformed cell lines<br />

may be immortal, enabling them to be propagated indefinitely<br />

in culture.<br />

cell-mediated hypersensitivity<br />

Refer to delayed-type hypersensitivity and to type IV cellmediated<br />

hypersensitivity.<br />

cell-mediated immune response<br />

Host defense mediated by antigen-specific T lymphocytes<br />

together with nonspecific cells of the immune system. The<br />

response offers protection against intracellular bacteria,<br />

viruses, and neoplasms and mediates graft rejection. It may<br />

be transferred passively with primed T lymphocytes.<br />

cell-mediated immunity (CMI)<br />

The limb of the immune response mediated by antigenspecific<br />

effector T cells that produce their effect through<br />

direct reaction, in contrast to the indirect effect mediated by<br />

antibodies of the humoral limb produced by B lymphocytes.<br />

CMI also includes the effector functions of natural killer<br />

(NK) and NKT cells. The development of cell-mediated<br />

immunity to an exogenous antigen first involves processing<br />

of the antigen by an antigen-presenting cell such as a macrophage.<br />

Processed antigen is presented in the context of<br />

major histocompatibility complex (MHC) class II molecules<br />

to a CD4 + T lymphocyte. IL1β is also released from the<br />

macrophage to induce IL2 synthesis in CD4 + lymphocytes.<br />

The IL2 has an autocrine effect on the cells producing it,<br />

causing their proliferation and also causing proliferation<br />

of other lymphocyte subsets including CD8 + suppressor/<br />

cytotoxic T cells, B lymphocytes that form antibodies, and<br />

NK cells. Cell-mediated immunity is critical in defenses<br />

against mycobacterial and fungal infections and resistance<br />

to tumors, and it has a role in allograft rejection.<br />

4–5 days<br />

added<br />

3 hours<br />

Cell-mediated lympholysis test.<br />

cell-mediated immunodeficiency syndrome<br />

Condition in which cell-mediated immunity is defective. It<br />

may be manifested as negative skin test results following the<br />

application of tuberculin, histoplasmin, or other common<br />

skin test antigens; failure to develop contact hypersensitivity<br />

following application of sensitizing substances such as dinitrochlorobenzene<br />

(DNCB) to the skin; or failure to reject an<br />

allograft, such as a skin graft. Severe combined immunodeficiency<br />

(SCID) is characterized by defective T lymphocyte<br />

and B lymphocyte limbs of the immune response. DiGeorge<br />

syndrome is characterized by failure of development of the<br />

T-cell-mediated limb of the immune response.<br />

cell-mediated lympholysis (CML) test<br />

Responder (effector) lymphocytes are cytotoxic for donor<br />

(target) lymphocytes after the two are combined in culture.<br />

Target cells are labeled by incubation with 51 Cr at<br />

37°C for 60 minutes. Following combination of effector<br />

and target cells in tissue culture, the release of 51 Cr from<br />

target cells injured by cytotoxicity represents a measure of<br />

cell-mediated lympholysis (CML). The CML assay gives<br />

uniform results, is relatively simple to perform, and is rather<br />

easily controlled. The effector cells can result from in vivo<br />

sensitization following organ grafting or can be induced in<br />

vitro. Variations in the ratio of effector to target cell can be<br />

employed for quantification.<br />

cell separation methods<br />

Early cell separation techniques were based in the<br />

early 1960s on differences such as cell size and density.<br />

Subsequently, membrane receptors or surface antigens were<br />

found to be differently expressed by lymphocyte subsets.<br />

Currently, the most popular lymphocyte separation techniques<br />

include immunoselection procedures that employ<br />

monoclonal antibodies. The two methods used for lymphocyte<br />

separation based on physical differences include sedimentation<br />

separation and density gradient separation. Other<br />

methods are based on functional properties of cells such as<br />

adhesive or phagocytic properties. Selected mononuclear cell<br />

types can adhere to plastic surfaces or to nylon wool. Other<br />

techniques employ selective depletion of cells such as lymphocytes<br />

undergoing proliferation. Mitogens in culture can<br />

be employed to select given lymphocyte populations based<br />

on their ability to respond to these stimulants. Rosetting techniques<br />

permit the detection or purification of cells expressing<br />

a certain surface receptor for antigen. Immunoselection techniques<br />

employ either monoclonal or polyclonal antibodies<br />

Culture<br />

medium<br />

containing<br />

51 Cr<br />

Target cells (chromium-labeled)<br />

Stimulating (sensitizing) cells<br />

Responding (effector) cells<br />

C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!